MedTrace Logo

Nutrition and Lifestyle Study Cohort of Gastric Cancer in China

NCT02216955 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2018-02-20

No results posted yet for this study

Summary

China has the largest gastric cancer patients population all over the world. Recent reports concluded nutrition status and lifestyle factors were associated with gastric cancer risk, however, the influence of nutrition and lifestyle factors on cancer outcome in gastric cancer survivors is largely unknown.The investigators will explore the impact of nutrition status, life style, dietary pattern, obesity, physical activity, depression, diabetes, aspirin use and vitamin supplement on gastric cancer outcome. The investigators will recruit approximately 50,000 patients as a prospective study cohort. During follow up, the investigators will explore the association of these factors with disease-specific survival, disease-free survival and overall survival of patients. The investigators believe that this project will facilitate the establishment of domestic nutrition and lifestyle data of gastric cancer of China, and the improvement of the quality of clinical management of patients with gastric cancer.

Conditions

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER

  • Tianjin Union Medical Center

    collaborator OTHER

  • Chengdu Medical College

    collaborator OTHER

  • Beihua University

    collaborator OTHER

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Second Military Medical University

    collaborator OTHER

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Peking University Cancer Hospital & Institute

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Third Military Medical University

    collaborator OTHER

  • State Key Laboratory of Cancer Biology

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02216955 on ClinicalTrials.gov